Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History AXDX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics AXDX

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Accelerate Diagnostics Inc

AXDX
Current price
0.0055 USD -0.035 USD (-86.25%)
Last closed 0.0054 USD
ISIN US00430H1023
Sector Healthcare
Industry Medical Devices
Exchange NASDAQ
Capitalization 859 917 USD
Yield for 12 month -99.52 %
1Y
3Y
5Y
10Y
15Y
AXDX
21.11.2021 - 28.11.2021

Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States and internationally. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing (AST) of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides Accelerate PhenoTest BC Kit, a test kit for the system, which is indicated as an aid, in conjunction with other clinical and laboratory findings, in the diagnosis of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. In addition, the company offers Accelerate Arc system, an instrument and associated one-time-use test kit that automates the clean-up and concentration of microbial cells from positive blood culture samples. Further, it develops Accelerate WAVE system, which performs AST directly from positive blood culture bottles and bacterial isolate colonies to report minimum inhibitory concentrations. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was incorporated in 1982 and is headquartered in Tucson, Arizona. On May 8, 2025, Accelerate Diagnostics, Inc., along with its affiliate, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware. Address: 3950 South Country Club Road, Tucson, AZ, United States, 85714

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

1.50 USD

P/E Ratio

Dividend Yield

Financials AXDX

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures AXDX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+11 698 000 USD

Last Year

+12 059 000 USD

Current Quarter

+2 816 000 USD

Last Quarter

+2 816 000 USD

Current Year

+2 704 000 USD

Last Year

+2 550 000 USD

Current Quarter

+449 000 USD

Last Quarter

+449 000 USD
EBITDA -31 889 000 USD
Operating Margin TTM -281.68 %
Price to Earnings
Return On Assets TTM -73.66 %
PEG Ratio -0.55
Return On Equity TTM
Wall Street Target Price 1.50 USD
Revenue TTM 11 698 000 USD
Book Value -2.23 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -7.00 %
Dividend Yield
Gross Profit TTM 2 704 000 USD
Earnings per share -2.15 USD
Diluted Eps TTM -2.15 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin

Stock Valuation AXDX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 4.31
Price Sales TTM 0.074
Enterprise Value EBITDA -1.10
Price Book MRQ

Technical Indicators AXDX

For 52 Weeks

0.012 USD 2.09 USD
50 Day MA 0.53 USD
Shares Short Prior Month 292 807
200 Day MA 1.25 USD
Short Ratio 6.15
Shares Short 297 377
Short Percent 1.90 %